Skip to main content
. Author manuscript; available in PMC: 2014 Apr 24.
Published in final edited form as: J Genet Syndr Gene Ther. 2014 Jan 24;5(2):216. doi: 10.4172/2157-7412.100021610.4172/2157-7412.1000216

Table 5.

Relation of the Apo B Gene Genotype with the Lipid and Polipoprotein Spectrum of Blood in the Uighurs with Coronary Heart Disease (CHD)

Parameters (mmol/l) X1X1 (n-48) X1X2 (n-25) X2X2 (n-7) P1 P2 P3
TC (mmol/l) 5.50 ± 0.12 5.60 ± 0.15 6.2 ± 0.21 >0,05 <0,05 <0,05
HDLC 1.18 ± 0.04 1.19 ± 0.06 1.16 ± 0.11 >0,05 >0,05 >0,05
LDLC 3.91± 0.10 4.0 ± 0.13 4.64 ± 0.20 >0,05 <0,05 <0,05
VLDLPC 0.41 ± 0.02 0.41 ± 0.04 0.4 ± 0.05 >0,05 >0,05 >0,05
TG 2.04 ± 0.08 2.04 ± 0.09 1.98 ± 0.14 >0,05 >0,05 >0,05
AI 3.66 ± 0.14 3.71 ± 0.15 4.34 ± 0.23 >0,05 <0,05 <0,05
Apo A1 (mg/dl) 130.6 ± 2.2 128.1 ± 3.7 127.2 ± 4.1 >0,05 >0,05 >0,05
Apo B (mg/dl) 88.98 ± 2.63 93.09 ± 2.97 107.4 ± 3.45 >0,05 <0,05 <0,05
Apo E (mg/dl) 4.3 ± 0.10 3.9 ± 0.16 3.7 ± 0.28 >0,05 >0,05 >0,05

Note: P1 – Statistical differences of lipid parameters in patients with the X1X1 and X1X2 genotypes, P2 - Statistical differences of lipid parameters in patients with the X1X1 and X2X2 genotypes, P3 - Statistical differences of lipid parameters in patients with the X1X2 and X2X2 genotypes.